Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. | Cancer Res;59(11): 2623-8, 1999 Jun 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy.

Heise, C C; Williams, A M; Xue, S; Propst, M; Kirn, D H.

Affiliation

Heise CC; ONYX Pharmaceuticals, Richmond, California 94806, USA.

Cancer Res ; 59(11): 2623-8, 1999 Jun 01.

Article in En | MEDLINE | ID: mdl-10363984

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Genetic Therapy / Adenoviridae / Defective Viruses / Genetic Vectors / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Genetic Therapy / Adenoviridae / Defective Viruses / Genetic Vectors / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 1999 Document type: Article Affiliation country: Country of publication: